MedTrace Logo

HFNC Vs LFNC in Patients with AF Undergoing RFCA Under Deep Sedation.

NCT04842253 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2025-02-20

No results posted yet for this study

Summary

Oxygen supplementation through high flow nasal cannula (HFNC) may reduce the incidence of desaturation and hypoxemia during deep sedation at radiofrequency catheter ablation (RFCA procedures).This study is designed to test the hypothesis that the incidence of hypoxemia and desaturation in patients with atrial fibrillation undergoing RFCA under deep sedation, is less when using HFNC as compared to use of standard low flow nasal cannula (LFNC).

Conditions

  • Deep Sedation
  • Oxygen Therapy
  • Radiofrequency Ablation

Interventions

DEVICE

High flow nasal cannula

HFNC during deep sedation undergoing radiofrequency ablation for atrial fibrillation.

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Esther AC Bouman, Doctor · Maastricht University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-04
Primary Completion
2024-11-18
Completion
2024-11-18

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04842253 on ClinicalTrials.gov